Edwards Lifesciences (EW) Other Non-Current Liabilities (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly Other Non-Current Liabilities of $350.7 million for Q1 2026, down 1.93% year-over-year from $357.6 million in Q1 2025, and down 3.2% quarter-over-quarter from $362.3 million in Q4 2025.
Edwards Lifesciences (EW) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Edwards Lifesciences' Other Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $350.7 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 1.93% year-over-year to $350.7 million; the TTM figure through Mar 2026 stood at $350.7 million (down 1.93% YoY), while the FY2025 annual figure was $362.3 million, down 2.95% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $350.7 million, down from $362.3 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $379.2 million in Q2 2025, with the low at $217.5 million in Q4 2022.
- The 5-year median for Other Non-Current Liabilities is $336.6 million (2024), against an average of $307.1 million.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities decreased 19.75% in 2022, then jumped 48.55% in 2024.
- Edwards Lifesciences' Other Non-Current Liabilities stood at $217.5 million in 2022, then increased by 15.54% to $251.3 million in 2023, then soared by 48.55% to $373.3 million in 2024, then fell by 2.95% to $362.3 million in 2025, then retreated by 3.2% to $350.7 million in 2026.
- Business Quant data shows EW's Other Non-Current Liabilities at $350.7 million in Q1 2026, $362.3 million in Q4 2025, and $362.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.32 Bn | 18.91 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 572.20 Mn |
| Mar 31, 2026 | 350.70 Mn |
| Dec 31, 2025 | 362.30 Mn |
| Sep 30, 2025 | 362.60 Mn |
| Jun 30, 2025 | 379.20 Mn |
| Mar 31, 2025 | 357.60 Mn |
| Dec 31, 2024 | 373.30 Mn |
| Sep 30, 2024 | 345.60 Mn |
| Jun 30, 2024 | 343.20 Mn |
| Mar 31, 2024 | 336.60 Mn |
| Dec 31, 2023 | 251.30 Mn |
| Sep 30, 2023 | 240.30 Mn |
| Jun 30, 2023 | 242.70 Mn |
| Mar 31, 2023 | 284.00 Mn |
| Dec 31, 2022 | 217.50 Mn |
| Sep 30, 2022 | 221.10 Mn |
| Jun 30, 2022 | 282.40 Mn |
| Mar 31, 2022 | 270.70 Mn |
| Dec 31, 2021 | 191.30 Mn |
| Sep 30, 2021 | 275.50 Mn |